Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-6.93%
↓ 115% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
44.77%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -6.93% |
| Q3 2025 | 22.12% |
| Q2 2025 | -8.67% |
| Q1 2025 | -41.27% |
| Q4 2024 | -65.38% |
| Q3 2024 | 26.20% |
| Q2 2024 | -3.01% |
| Q1 2024 | 24.19% |
| Q4 2023 | -99.07% |
| Q3 2023 | -113.22% |
| Q2 2023 | 875.63% |
| Q1 2023 | -28.62% |
| Q4 2022 | 0.00% |